SLC2A1 and breast carcinoma: The degradation of HIF-1α accelerates the reversal of the expression of glycolysis-related proteins GLUT1, PDK1, and HK2 in cancer cells, which weakens the glycolysis of breast cancer cells and indirectly leads to tumor growth inhibition.